Mitochondrial DNA Copy Number as a Marker and Mediator of Stroke Prognosis

Abstract

This study provides Class II evidence that low buffy coat mtDNA-CN (>1 SD) was associated with worse baseline severity and 1-month outcomes in patients with ischemic or hemorrhagic stroke.